Henderson Jeffrey William Insider Trades

Insider Trading History

Track insider trading activity for Henderson Jeffrey William. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Halozyme Therapeutics
Halozyme Therapeutics HALO
Director
Holding Value $2.55M 36,572 shares
Last Trade
May 05, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$648k 9,836 shares
$65.87
$69.62
Qualcomm
Qualcomm QCOM
Director
Holding Value $2.98M 14,598 shares
Last Trade
Mar 17, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$337k 2,563 shares
$131.53
$204.13
Qualcomm
Qualcomm QCOM
Director
Holding Value $2.61M 12,794 shares
Last Trade
Mar 08, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$319k 2,355 shares
$135.66
$204.13
Qualcomm
Qualcomm QCOM
Director
Holding Value $344k 1,683 shares
Last Trade
Mar 08, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$319k 2,355 shares
$135.66
$204.13
Qualcomm
Qualcomm QCOM
Director
Holding Value $2.46M 12,035 shares
Last Trade
Mar 08, 2026 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$103k 759 shares
$135.69
$204.13
Becton Dickinson
Becton Dickinson BDX
Director
Holding Value $1.32M 9,143 shares
Last Trade
Jan 27, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$176k 1,098 shares
$159.84
$143.92
Becton Dickinson Deposit Repr 1/20th Cum Conv Pfd Registered Series A
Becton Dickinson Deposit Repr 1/20th Cum Conv Pfd Registered Series A BDXA
Director
Holding Value $542k 9,143 shares
Last Trade
Jan 27, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$65k 1,098 shares
$59.24
$59.24
Becton, Dickinson And - 6% PRF CONVERT 01/06/2023 USD 50 - Ser B
Becton, Dickinson And - 6% PRF CONVERT 01/06/2023 USD 50 - Ser B BDXB
Director
Holding Value $440k 9,143 shares
Last Trade
Jan 27, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$52.9k 1,098 shares
$48.16
$48.16
Halozyme Therapeutics
Halozyme Therapeutics HALO
Director
Holding Value $2.28M 32,776 shares
Last Trade
May 01, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$345k 5,750 shares
$60.03
$69.62
Halozyme Therapeutics
Halozyme Therapeutics HALO
Director
Holding Value $2.01M 28,811 shares
Last Trade
Apr 28, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$271k 4,497 shares
$60.37
$69.62
Halozyme Therapeutics
Halozyme Therapeutics HALO
Director
Holding Value $2.3M 33,108 shares
Last Trade
Apr 01, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$32.2k 503 shares
$64.05
$69.62
Qualcomm
Qualcomm QCOM
Director
Holding Value $2.12M 10,406 shares
Last Trade
Mar 18, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$328k 2,097 shares
$156.29
$204.13
Qualcomm
Qualcomm QCOM
Director
Holding Value $1.7M 8,309 shares
Last Trade
Mar 09, 2025 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$306k 1,901 shares
$161.22
$204.13
Qualcomm
Qualcomm QCOM
Director
Holding Value $804k 3,938 shares
Last Trade
Mar 09, 2025 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$306k 1,901 shares
$161.22
$204.13
Halozyme Therapeutics
Halozyme Therapeutics HALO
Director
Holding Value $2.56M 36,816 shares
Last Trade
Mar 03, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$293k 5,000 shares
$58.69
$69.62
Becton Dickinson Deposit Repr 1/20th Cum Conv Pfd Registered Series A
Becton Dickinson Deposit Repr 1/20th Cum Conv Pfd Registered Series A BDXA
Director
Holding Value $475k 8,015 shares
Last Trade
Feb 10, 2025 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$88.9k 1,500 shares
$59.24
$59.24
Becton Dickinson
Becton Dickinson BDX
Director
Holding Value $1.15M 8,015 shares
Last Trade
Feb 10, 2025 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$350k 1,500 shares
$233.62
$143.92
Becton, Dickinson And - 6% PRF CONVERT 01/06/2023 USD 50 - Ser B
Becton, Dickinson And - 6% PRF CONVERT 01/06/2023 USD 50 - Ser B BDXB
Director
Holding Value $386k 8,015 shares
Last Trade
Feb 10, 2025 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$72.2k 1,500 shares
$48.16
$48.16
Halozyme Therapeutics
Halozyme Therapeutics HALO
Director
Holding Value $2.96M 42,511 shares
Last Trade
Feb 03, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$282k 5,000 shares
$56.31
$69.62
Becton Dickinson Deposit Repr 1/20th Cum Conv Pfd Registered Series A
Becton Dickinson Deposit Repr 1/20th Cum Conv Pfd Registered Series A BDXA
Director
Holding Value $386k 6,515 shares
Last Trade
Jan 28, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$55.1k 930 shares
$59.24
$59.24

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up